BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 28358012)

  • 1. Suppression of FOXM1 Transcriptional Activities via a Single-Stranded DNA Aptamer Generated by SELEX.
    Xiang Q; Tan G; Jiang X; Wu K; Tan W; Tan Y
    Sci Rep; 2017 Mar; 7():45377. PubMed ID: 28358012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cell-penetrating FOXM1 N-terminus (M1-138) demonstrates potent inhibitory effects on cancer cells by targeting FOXM1 and FOXM1-interacting factor SMAD3.
    Zhang Z; Bu H; Yu J; Chen Y; Pei C; Yu L; Huang X; Tan G; Tan Y
    Theranostics; 2019; 9(10):2882-2896. PubMed ID: 31244930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasound-mediated nanobubble destruction (UMND) facilitates the delivery of A10-3.2 aptamer targeted and siRNA-loaded cationic nanobubbles for therapy of prostate cancer.
    Wu M; Zhao H; Guo L; Wang Y; Song J; Zhao X; Li C; Hao L; Wang D; Tang J
    Drug Deliv; 2018 Nov; 25(1):226-240. PubMed ID: 29313393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of the FOXM1 transcriptional programme via novel small molecule inhibition.
    Gormally MV; Dexheimer TS; Marsico G; Sanders DA; Lowe C; Matak-Vinković D; Michael S; Jadhav A; Rai G; Maloney DJ; Simeonov A; Balasubramanian S
    Nat Commun; 2014 Nov; 5():5165. PubMed ID: 25387393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metadherin/Astrocyte elevated gene-1 positively regulates the stability and function of forkhead box M1 during tumorigenesis.
    Yang L; He K; Yan S; Yang Y; Gao X; Zhang M; Xia Z; Huang Z; Huang S; Zhang N
    Neuro Oncol; 2017 Mar; 19(3):352-363. PubMed ID: 27923917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of HBsAg DNA aptamer using modified cell-based SELEX strategy.
    Mirian M; Kouhpayeh S; Shariati L; Boshtam M; Rahimmanesh I; Darzi L; Taghizadeh R; Jahanian-Najafabadi A; Khanahmad H
    Mol Biol Rep; 2021 Jan; 48(1):139-146. PubMed ID: 33400073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro selection and characterization of a DNA aptamer targeted to Prorocentrum minimum-A common harmful algae.
    Liu F; Zhang C; Duan Y; Ma J; Wang Y; Chen G
    Sci Total Environ; 2022 Jul; 830():154771. PubMed ID: 35339548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of the master regulator FOXM1 in cancer.
    Liao GB; Li XZ; Zeng S; Liu C; Yang SM; Yang L; Hu CJ; Bai JY
    Cell Commun Signal; 2018 Sep; 16(1):57. PubMed ID: 30208972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LXRα-mediated downregulation of FOXM1 suppresses the proliferation of hepatocellular carcinoma cells.
    Hu C; Liu D; Zhang Y; Lou G; Huang G; Chen B; Shen X; Gao M; Gong W; Zhou P; Dai S; Zeng Y; He F
    Oncogene; 2014 May; 33(22):2888-97. PubMed ID: 23812424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel peptide, 9R-P201, strongly inhibits the viability, proliferation and migration of liver cancer HepG2 cells and induces apoptosis by down-regulation of FoxM1 expression.
    Bi Z; Liu W; Ding R; Wu Y; Dou R; Zhang W; Yuan X; Liu X; Xiong L; Guo Z; Mao C
    Eur J Pharmacol; 2017 Feb; 796():175-189. PubMed ID: 28012972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The isolation of an RNA aptamer targeting to p53 protein with single amino acid mutation.
    Chen L; Rashid F; Shah A; Awan HM; Wu M; Liu A; Wang J; Zhu T; Luo Z; Shan G
    Proc Natl Acad Sci U S A; 2015 Aug; 112(32):10002-7. PubMed ID: 26216949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a FOXM1-DBD Binding Assay for High-Throughput Screening Using TR-FRET Assay.
    Lee MY; Haam CE; Mun J; Lim G; Lee BH; Oh KS
    Biol Pharm Bull; 2021; 44(10):1484-1491. PubMed ID: 34602556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reciprocal Regulation Between Forkhead Box M1/NF-κB and Methionine Adenosyltransferase 1A Drives Liver Cancer.
    Li Y; Lu L; Tu J; Zhang J; Xiong T; Fan W; Wang J; Li M; Chen Y; Steggerda J; Peng H; Chen Y; Li TWH; Zhou ZG; Mato JM; Seki E; Liu T; Yang H; Lu SC
    Hepatology; 2020 Nov; 72(5):1682-1700. PubMed ID: 32080887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution of a gastric carcinoma cell-specific DNA aptamer by live cell-SELEX.
    Cao HY; Yuan AH; Shi XS; Chen W; Miao Y
    Oncol Rep; 2014 Nov; 32(5):2054-60. PubMed ID: 25175855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [DNA aptamer selection in vitro for determining ketamine by FluMag-SELEX].
    Sun MQ; Cao FQ; Hu XL; Zhang YR; Lu XW; Zeng LB
    Fa Yi Xue Za Zhi; 2014 Oct; 30(5):346-9. PubMed ID: 25735070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aptamer Selection for Detecting Molecular Target Using Cell-SELEX (Systematic Evolution of Ligands by Exponential Enrichment) Technology.
    Stewart KD; Tan W; Park JY
    Methods Mol Biol; 2019; 2054():223-241. PubMed ID: 31482459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FOXM1 is a transcriptional target of ERalpha and has a critical role in breast cancer endocrine sensitivity and resistance.
    Millour J; Constantinidou D; Stavropoulou AV; Wilson MS; Myatt SS; Kwok JM; Sivanandan K; Coombes RC; Medema RH; Hartman J; Lykkesfeldt AE; Lam EW
    Oncogene; 2010 May; 29(20):2983-95. PubMed ID: 20208560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Forkhead box transcription factor FOXM1 is required for the maintenance of cell proliferation and protection against oxidative stress in human embryonic stem cells.
    Kwok CT; Leung MH; Qin J; Qin Y; Wang J; Lee YL; Yao KM
    Stem Cell Res; 2016 May; 16(3):651-61. PubMed ID: 27062359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An improved SELEX technique for selection of DNA aptamers binding to M-type 11 of Streptococcus pyogenes.
    Hamula CL; Peng H; Wang Z; Tyrrell GJ; Li XF; Le XC
    Methods; 2016 Mar; 97():51-7. PubMed ID: 26678795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PRRX1 isoforms cooperate with FOXM1 to regulate the DNA damage response in pancreatic cancer cells.
    Marchand B; Pitarresi JR; Reichert M; Suzuki K; Laczkó D; Rustgi AK
    Oncogene; 2019 May; 38(22):4325-4339. PubMed ID: 30705403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.